Natural selection shapes genomes to evolve and to adapt but, are the rules of natural selection also applying to cancer genome evolution? Researchers suggest negative selection acting on cancer-essential genes plays a more important role than previously anticipated.
Scientists have published one of the most detailed maps ever made of structural variations in a cancer cell’s genome.
A new method makes it possible to systematically identify specialised proteins that unpack DNA inside the nucleus of a cell, making the usually dense DNA more accessible for gene expression and other functions.
Dr. Mark McClellan joined Johnson & Johnson’s board of directors after leaving the FDA, but the connection often isn’t mentioned in research papers or public events.
Personalised medicine has been a goal of researchers and doctors for a long time. Now, researchers have developed what they call a personalised Therapeutic Intervention Fingerprint (pTIF), for patients with neurological disease.
Researchers at Harvard Medical School have found further evidence that supports the notion that viruses could help cause the onset of Alzheimer’s disease; an idea that was once ridiculed by other sceptics and researchers.
Researchers have designed nanoparticles that can be attached to T-cells and release T-cell-stimulating molecules called cytokines, that activate T-cells to attack nearby tumour cells.
Even in light of the rising fears of “superbugs” in the world of big pharma, the marginal profits made through the development of antibiotics isn’t enough to justify the research.
Scientists have developed a technique that shows individual cancer cells in a tumour in real-time, revealing which cells that interact with a drug and which cells the drug fails to reach.
One year after researchers published their work on a physiological test for autism, a follow-up study has confirmed its exceptional success in assessing whether a child is on the autism spectrum.
Scientists are taking advantage of the “self-homing” abilities of cancer cells and are creating armies of cancer-killing cells using CRISPR gene-editing.
A new type of zebrafish that produces fluorescent tags in migratory embryonic nerve precursor cells could help researchers find the origins of the third-most common pediatric cancer in the U.S.